Developer docs
API playgroundTry for free, no card

Search company profiles

Pixelgen Technologies

Full company profile

uuid00023m5

Namestring
Pixelgen Technologies
Legal namestring
Pixelgen Technologies AB
Websiteurl
pixelgen.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Pixelgen Technologies AB is a Stockholm-based, venture-backed life sciences tools company founded in 2020 that develops and sells spatial proteomics kits for analyzing cell surface protein organization on single immune cells. Its core technologies are the patented Proximity Network Assay (PNA) and the earlier Molecular Pixelation (MPX) platform, which use DNA-barcoded antibodies, rolling circle amplification, proximity oligos, and gap-fill ligation to build protein proximity networks that are read out on standard next-generation sequencing instruments (Illumina, MGI, Roche, Ultima, AVITI) without specialist imaging hardware. The flagship product is the Proxiome Kit v2 (Immuno 155 v2), a sample-prep consumable covering 155 cell surface proteins at ~50 nm resolution, with add-on modules for custom antibody conjugation and detection of engineered CAR T cells. An open-source analysis suite (pixelator Python CLI, pixelatorR R package, pixelatorES, nf-core/pixelator Nextflow pipeline) integrates with Scanpy, Seurat, Nextflow, Docker, Singularity, and Conda. Pixelgen monetizes primarily through one-time kit and reagent sales, quote-based pricing with volume tiers, and a US service-provider channel via Carolina Molecular. Customers are academic and translational researchers in immunology, immuno-oncology, hematology, and cell therapy, plus biopharma drug discovery teams; distribution is direct in the US and Europe, and via non-exclusive partners (BioStream, Australian Biosearch, MDxK) across APAC.

Short descriptiontext

Pixelgen Technologies is a Stockholm-based life sciences company developing Proximity Network Assay and Molecular Pixelation kits for spatial proteomics analysis of single immune cells. It serves academic researchers and biopharmaceutical firms in immunology, oncology, hematology, and cell therapy through direct sales and global distribution partners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersStockholm, Sweden
HQ citystring
Stockholm
HQ countrystring
Sweden
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
spatial proteomics kits, single-cell analysis, proximity network assay, molecular pixelation, cell surface proteomics
Industry3 codes
PRIMARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)
SECONDARYHLAAAMAK
Immuno-Oncology & Immune Monitoring Biomarkers (TMB, MSI, MRD, immune profiling)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
NAICS code1 code
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Spatial Proteomics
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Spatial Proteomics Kits and Reagents
TypeOne Time License
Description

Pixelgen generates revenue primarily through the sale of its Proxiome Kit product line, including the Proxiome Kit v2 (Immuno 155), Custom Conjugation Kit, and CAR T detection products. These are consumable sample prep kits sold in configurable reaction formats (8, 16, 32 reactions). The company also offers volume-based pricing discounts for larger kit configurations.

pixelgen.com
2Service Provider Network Revenue
TypeOne Time License
Description

Through certified service providers (e.g., Carolina Molecular in the US), Pixelgen enables third-party labs to run its assays on behalf of end customers who lack in-house capabilities. This extends the commercial reach of the product without requiring direct sales to every end user.

pixelgen.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
Pricing details7 tiers
1Proxiome Kit v2, Immuno 155 v2 — 8 reactions
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Part nr.: PROXIMM0028. 8-reaction format for running up to 8 samples (or 64 with high-throughput configuration).

pixelgen.com
2Proxiome Kit v2, Immuno 155 v2 — 16 reactions
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Part nr.: PROXIMM00216. 16-reaction format with volume-based discount pricing.

pixelgen.com
3Proxiome Kit v2, Immuno 155 v2 — 32 reactions
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Part nr.: PROXIMM00232. 32-reaction format at largest-volume discount tier.

pixelgen.com
4Proxiome v2 Custom Conjugation Kit — 2x Mouse IgG1
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Part nr.: PROXCUST001. Enables 2 custom mouse IgG1 antibodies per experiment.

pixelgen.com
5Proxiome v2 Custom Conjugation Kit — 2x other host/subclass
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Part nr.: PROXCUST002. Supports alternative antibody subclasses/species.

pixelgen.com
6Proxiome v2 Custom Conjugation Kit — 1x Mouse IgG1 + 1x other
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Part nr.: PROXCUST003. Mixed configuration for flexibility.

pixelgen.com
7Proxiome CAR-T Barcoded Antibodies (FMC63, FLAG, G4S)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

PP102 (FMC63), PP103 (FLAG), PP104 (G4S). Spike-in reagents for CAR detection in Proxiome workflow.

pixelgen.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Pixelgen Technologies develops and sells the Proximity Network Assay (PNA)-powered Proxiome Kit, a sample-preparation reagent kit that uses DNA-barcoded antibodies, rolling circle amplification, and next-generation sequencing to map protein abundance, clustering, and colocalization on the surface of single immune cells at nanoscale (~50nm) resolution. The offering includes complementary modules (Custom Conjugation Kit for user-defined antibodies, CAR T barcoded spike-in antibodies), along with an open-source software suite (pixelator, pixelatorR, nf-core/pixelator, pixelatorES) for data processing and analysis on standard NGS platforms.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 3.7-fold increase in signal-to-noise ratio and 2.2x more data per cell with MPX v2 compared to v1
+4 more records
Product overview1 text field

Pixelgen Technologies offers a platform-plus-modules architecture centered on spatial proteomics technology for single-cell analysis. The core Proxiome Kit v2 (Immuno 155) provides high-dimensional cell surface architecture analysis with 155 protein targets, which can be extended via the Custom Conjugation Kit (for custom antibody targets) and CAR T Antibodies (for CAR detection). The technology is powered by either the first-generation Molecular Pixelation (MPX) or second-generation Proximity Network Assay (PNA) platforms. Data analysis is enabled through a software suite including pixelator (Python CLI), pixelatorR (R package), pixelatorES (R reporting), and nf-core/pixelator (Nextflow pipeline), all integrated with standard bioinformatics tools like Scanpy, Seurat, and Nextflow for reproducible workflows on Illumina, MGI, Roche, Ultima Genomics, and AVITI sequencing platforms.

Product and service7 records
1Pixelgen Proxiome Kit v2 (Immuno 155 v2)
CategorySpatial proteomics sample preparation kit
Description

High-dimensional analysis kit for cell surface architecture in single human immune cells, generating readouts on protein abundance, protein clustering, and protein colocalization for 155 surface proteins at nanoscale (~50nm) resolution. Supports up to 64 samples per experiment and ~1,000 single cells per sample. Runs on standard NGS platforms without specialized imaging hardware.

2Pixelgen Proxiome v2 Custom Conjugation Kit
CategorySpatial proteomics add-on kit
Description

Add-on kit enabling integration of user-defined monoclonal antibodies into the Proxiome Kit v2 workflow, allowing tailored analysis of additional cell surface targets together with high-dimensional profiling of cell surface architecture. Supports up to two custom antibodies per experiment across three configurations.

3Pixelgen Proxiome CAR T Barcoded Antibodies (FMC63, FLAG, G4S)
CategorySpatial proteomics add-on kit (CAR T reagents)
Description

Barcoded antibody spike-ins for the Proxiome Immuno 155 panel enabling CAR detection and spatial profiling of engineered CAR T cells within clinical samples. Includes anti-FLAG (PP103), anti-FMC63 (PP102), and anti-G4S (PP104) reagents.

4pixelator
CategoryAnalysis software
Description

Open-source Python software library and CLI tool providing methods and algorithms for processing, analysis, and visualization of 3D protein interactomics data from MPX and PNA assays. Converts raw FASTQ sequencing data into PXL files ready for downstream analysis.

5pixelatorR
CategoryAnalysis software
Description

Open-source R software library for processing, analyzing, and visualizing Proximity Network assay (PNA) and Molecular Pixelation (MPX) single-cell data. Extends the Seurat toolbox with specialized S4 classes for spatial proteomics data structures.

6nf-core/pixelator
CategoryAnalysis pipeline
Description

Nextflow-based analysis pipeline for processing Proximity Network assay data. Part of the nf-core community project, enabling reproducible workflow execution on HPC clusters, cloud platforms, and local computing clusters.

7pixelatorES
CategoryAnalysis reporting software
Description

R package that generates Proxiome Summary Reports for multi-sample experiments, providing quick look at QC metrics, statistics, and visualizations. Automatically generated when running nf-core/pixelator v2.1+ with Proxiome Network Assay data.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-17
Description

Research collaboration to discover novel biomarkers for cancer immunotherapy response. Prof. Andreas Lundqvist's group will use Pixelgen's Proximity Network Assay to analyze the spatial distribution of over 150 cell surface proteins in non-small cell lung cancer patients undergoing immunotherapy. Results will be submitted for peer-reviewed publication and lay groundwork for future collaborations.

Strategic tierSignificantTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-12-15
Description

Distribution agreement for South Korea signed December 2025. MDxK distributes Pixelgen's Proxiome Kit in South Korea to support research advancements in immunology and cancer. This partnership further expands Pixelgen's distribution network in Asia following agreements with BioStream (Japan) and Australian Biosearch (ANZ).

3Dr. Aaron D. Viny (Columbia University)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-11-18
Description

Dr. Aaron Viny, internationally recognized physician-scientist at Columbia University Irving Medical Center, was appointed to Pixelgen's Scientific Advisory Board in November 2025. He focuses on clonal hematopoiesis, MDS, and AML. His research into 3D DNA architecture in blood cancers is expected to help advance Pixelgen's applications in blood diseases and cancer.

pixelgen.com
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-11-12
Description

Carolina Molecular became the first US certified service provider for Pixelgen's Proxiome Kit in November 2025. Provides academic, pharmaceutical, and biotech researchers across the US with access to Pixelgen's Proximity Network Assay for protein interactomics analysis. Leverages Carolina Molecular's NGS Foundry and bioinformatics capabilities for data delivery.

5Mostafa Ronaghi (Cellanome / Former Illumina CTO)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-04-30
Description

Renowned genomicist and serial entrepreneur appointed to Pixelgen's Scientific Advisory Board in April 2024. Previously served as CTO and SVP of entrepreneurial development at Illumina. Co-founded GRAIL and multiple successful life sciences companies. Brings deep expertise in genomics and entrepreneurial development to guide Pixelgen's commercial expansion.

pixelgen.com
Strategic tierSignificantTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-02-06
Description

Non-exclusive distribution agreement for Australia and New Zealand signed February 2024. Australian Biosearch brings Pixelgen's Molecular Pixelation kits to the ANZ region to meet growing customer demand. Australian Biosearch is well regarded for bringing innovative tools to industry and academia.

Strategic tierSignificantTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-02-01
Description

Non-exclusive distribution agreement for Japan signed February 2024. BioStream distributes Pixelgen's spatial proteomics kits to bioresearch institutions and companies in Japan. BioStream is a well-established distributor in Japan with many years of experience serving pharmaceutical and biotech companies.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Leading single-cell and spatial biology platform whose Xenium (in situ) and Visium products compete with Pixelgen in spatial omics for single cells. Several Pixelgen executives (Alvaro Martinez Barrio, Annika Branting, Brad Crutchfield, Tarjei Mikkelsen) are 10x alumni, and the platforms target overlapping academic and pharma customers.

TypeDirect peer
Description

Spatial biology competitor with CosMx SMI (single-molecule imaging) and GeoMx digital spatial profiling, directly addressing the same translational research and immuno-oncology customer base that Pixelgen's Proxiome Kit targets.

TypeDirect peer
Description

Spatial proteomics company offering PhenoCycler (single-cell) and PhenoImager (tissue) platforms that compete in immuno-oncology and tumor microenvironment applications highly overlapping with Pixelgen's CAR-T and immune-cell surface biology focus.

TypeBroad incumbent
Description

Proteomics tools company commercializing the Proximity Extension Assay—founded by Pixelgen CEO Simon Fredriksson. Operates a much broader installed base across pharma and academic proteomics; relevant as a precedent for scaling multiplex proteomics and a likely customer-overlap competitor.

TypeBroad incumbent
Description

Provider of mass cytometry and imaging mass cytometry instruments for single-cell proteomics, serving similar immunology and translational research customers with established imaging-based workflows that Pixelgen's optics-free approach seeks to complement or substitute.

TypeBroad incumbent
Description

Diversified life sciences tools company with proteomics reagents (ProteinSimple, R&D Systems) and spatial biology offerings. Provides a comparable consumables-and-instruments franchise across the same academic and biopharma proteomics buyers.

TypeEmerging player
Description

Single-cell functional proteomics platform targeting cell therapy and immuno-oncology characterization—directly comparable to Pixelgen's CAR-T and immune cell-surface profiling use cases in translational and clinical research.

TypeBroad incumbent
Description

Antibody discovery and immune profiling platform with single-cell B-cell sequencing capabilities relevant to immune cell characterization; competes for immuno-oncology and cell-therapy customer budget adjacent to Pixelgen's CAR-T and surface-proteomics applications.

TypeBroad incumbent
Description

Analytical instruments manufacturer with mass spectrometry and spatial proteomics/imaging mass cytometry solutions (e.g., timsTOF, CellScape). Overlaps with Pixelgen in translational proteomics customers and in serving immunology, hematology, and pharma research labs.

TypeBroad incumbent
Description

Major life sciences and diagnostics company with flow cytometry, single-cell multiomics (BD CellView, FACSDiscover), and cell therapy manufacturing tools. Competes for immunology and cell-therapy characterization budget that Pixelgen also targets with its Proxiome CAR-T products.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration10 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles17 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pixelgen Technologies

Spatial Proteomicspixelgen.com

Pixelgen Technologies is a Stockholm-based life sciences company developing Proximity Network Assay and Molecular Pixelation kits for spatial proteomics analysis of single immune cells. It serves academic researchers and biopharmaceutical firms in immunology, oncology, hematology, and cell therapy through direct sales and global distribution partners.

What Pixelgen Technologies does

Pixelgen Technologies AB is a Stockholm-based, venture-backed life sciences tools company founded in 2020 that develops and sells spatial proteomics kits for analyzing cell surface protein organization on single immune cells. Its core technologies are the patented Proximity Network Assay (PNA) and the earlier Molecular Pixelation (MPX) platform, which use DNA-barcoded antibodies, rolling circle amplification, proximity oligos, and gap-fill ligation to build protein proximity networks that are read out on standard next-generation sequencing instruments (Illumina, MGI, Roche, Ultima, AVITI) without specialist imaging hardware. The flagship product is the Proxiome Kit v2 (Immuno 155 v2), a sample-prep consumable covering 155 cell surface proteins at ~50 nm resolution, with add-on modules for custom antibody conjugation and detection of engineered CAR T cells. An open-source analysis suite (pixelator Python CLI, pixelatorR R package, pixelatorES, nf-core/pixelator Nextflow pipeline) integrates with Scanpy, Seurat, Nextflow, Docker, Singularity, and Conda. Pixelgen monetizes primarily through one-time kit and reagent sales, quote-based pricing with volume tiers, and a US service-provider channel via Carolina Molecular. Customers are academic and translational researchers in immunology, immuno-oncology, hematology, and cell therapy, plus biopharma drug discovery teams; distribution is direct in the US and Europe, and via non-exclusive partners (BioStream, Australian Biosearch, MDxK) across APAC.

Pixelgen Technologies firmographics

Firmographics
Name
Pixelgen Technologies
Legal name
Pixelgen Technologies AB
Website
https://pixelgen.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
Pixelgen Technologies is a Stockholm-based life sciences company developing Proximity Network Assay and Molecular Pixelation kits for spatial proteomics analysis of single immune cells. It serves academic researchers and biopharmaceutical firms in immunology, oncology, hematology, and cell therapy through direct sales and global distribution partners.
Ownership category
akta.pro rank

Pixelgen Technologies industry classification

Industry
Product category
Spatial Proteomics
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)
SECONDARYHLAAAMAK
Immuno-Oncology & Immune Monitoring Biomarkers (TMB, MSI, MRD, immune profiling)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)

Keywords

  • Spatial proteomics kits
  • Single-cell analysis
  • Proximity network assay
  • Molecular pixelation
  • Cell surface proteomics

Where Pixelgen Technologies is headquartered

Location

Headquarters

HQ city
Stockholm
HQ country
Sweden
HQ region
Europe

Offices1 record

Markets served

Pixelgen Technologies business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Spatial Proteomics Kits and Reagents: Pixelgen generates revenue primarily through the sale of its Proxiome Kit product line, including the Proxiome Kit v2 (Immuno 155), Custom Conjugation Kit, and CAR T detection products. These are consumable sample prep kits sold in configurable reaction formats (8, 16, 32 reactions). The company also offers volume-based pricing discounts for larger kit configurations.
  2. Service Provider Network Revenue: Through certified service providers (e.g., Carolina Molecular in the US), Pixelgen enables third-party labs to run its assays on behalf of end customers who lack in-house capabilities. This extends the commercial reach of the product without requiring direct sales to every end user.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goProxiome Kit v2, Immuno 155 v2 — 8 reactions
Unit PricingPay-as-you-goProxiome Kit v2, Immuno 155 v2 — 16 reactions
Unit PricingPay-as-you-goProxiome Kit v2, Immuno 155 v2 — 32 reactions
Unit PricingPay-as-you-goProxiome v2 Custom Conjugation Kit — 2x Mouse IgG1
Unit PricingPay-as-you-goProxiome v2 Custom Conjugation Kit — 2x other host/subclass
Unit PricingPay-as-you-goProxiome v2 Custom Conjugation Kit — 1x Mouse IgG1 + 1x other
Unit PricingPay-as-you-goProxiome CAR-T Barcoded Antibodies (FMC63, FLAG, G4S)

Go-to-market motion3 records

Distribution channels5 records

Marketing channels6 records

Pixelgen Technologies product offering

Product offering

Core offering

Pixelgen Technologies develops and sells the Proximity Network Assay (PNA)-powered Proxiome Kit, a sample-preparation reagent kit that uses DNA-barcoded antibodies, rolling circle amplification, and next-generation sequencing to map protein abundance, clustering, and colocalization on the surface of single immune cells at nanoscale (~50nm) resolution. The offering includes complementary modules (Custom Conjugation Kit for user-defined antibodies, CAR T barcoded spike-in antibodies), along with an open-source software suite (pixelator, pixelatorR, nf-core/pixelator, pixelatorES) for data processing and analysis on standard NGS platforms.

Product overview

Pixelgen Technologies offers a platform-plus-modules architecture centered on spatial proteomics technology for single-cell analysis. The core Proxiome Kit v2 (Immuno 155) provides high-dimensional cell surface architecture analysis with 155 protein targets, which can be extended via the Custom Conjugation Kit (for custom antibody targets) and CAR T Antibodies (for CAR detection). The technology is powered by either the first-generation Molecular Pixelation (MPX) or second-generation Proximity Network Assay (PNA) platforms. Data analysis is enabled through a software suite including pixelator (Python CLI), pixelatorR (R package), pixelatorES (R reporting), and nf-core/pixelator (Nextflow pipeline), all integrated with standard bioinformatics tools like Scanpy, Seurat, and Nextflow for reproducible workflows on Illumina, MGI, Roche, Ultima Genomics, and AVITI sequencing platforms.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pixelgen Proxiome Kit v2 (Immuno 155 v2) High-dimensional analysis kit for cell surface architecture in single human immune cells, generating readouts on protein abundance, protein clustering, and protein colocalization for 155 surface proteins at nanoscale (~50nm) resolution. Supports up to 64 samples per experiment and ~1,000 single cells per sample. Runs on standard NGS platforms without specialized imaging hardware.
  • Pixelgen Proxiome v2 Custom Conjugation Kit Add-on kit enabling integration of user-defined monoclonal antibodies into the Proxiome Kit v2 workflow, allowing tailored analysis of additional cell surface targets together with high-dimensional profiling of cell surface architecture. Supports up to two custom antibodies per experiment across three configurations.
  • Pixelgen Proxiome CAR T Barcoded Antibodies (FMC63, FLAG, G4S) Barcoded antibody spike-ins for the Proxiome Immuno 155 panel enabling CAR detection and spatial profiling of engineered CAR T cells within clinical samples. Includes anti-FLAG (PP103), anti-FMC63 (PP102), and anti-G4S (PP104) reagents.
  • pixelator Open-source Python software library and CLI tool providing methods and algorithms for processing, analysis, and visualization of 3D protein interactomics data from MPX and PNA assays. Converts raw FASTQ sequencing data into PXL files ready for downstream analysis.
  • pixelatorR Open-source R software library for processing, analyzing, and visualizing Proximity Network assay (PNA) and Molecular Pixelation (MPX) single-cell data. Extends the Seurat toolbox with specialized S4 classes for spatial proteomics data structures.
  • nf-core/pixelator Nextflow-based analysis pipeline for processing Proximity Network assay data. Part of the nf-core community project, enabling reproducible workflow execution on HPC clusters, cloud platforms, and local computing clusters.
  • pixelatorES R package that generates Proxiome Summary Reports for multi-sample experiments, providing quick look at QC metrics, statistics, and visualizations. Automatically generated when running nf-core/pixelator v2.1+ with Proxiome Network Assay data.

Quantifiable outcome

  • 3.7-fold increase in signal-to-noise ratio and 2.2x more data per cell with MPX v2 compared to v1
  • +4 more outcomes

Companies that use Pixelgen Technologies

Customer profile

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Pixelgen Technologies technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration10 records

Feature6 records

Pixelgen Technologies partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core, significant and minor.

  • Karolinska Institutet (Andreas Lundqvist Research Group)coreStrategic or Co-development Partner · 17 March 2026Research collaboration to discover novel biomarkers for cancer immunotherapy response. Prof. Andreas Lundqvist's group will use Pixelgen's Proximity Network Assay to analyze the spatial distribution of over 150 cell surface proteins in non-small cell lung cancer patients undergoing immunotherapy. Results will be submitted for peer-reviewed publication and lay groundwork for future collaborations.
  • MDxK / Molecular Diagnostics Korea (South Korea)significantChannel Partner/ Reseller/ Distributor · 15 December 2025Distribution agreement for South Korea signed December 2025. MDxK distributes Pixelgen's Proxiome Kit in South Korea to support research advancements in immunology and cancer. This partnership further expands Pixelgen's distribution network in Asia following agreements with BioStream (Japan) and Australian Biosearch (ANZ).
  • Dr. Aaron D. Viny (Columbia University)minorStrategic or Co-development Partner · 18 November 2025Dr. Aaron Viny, internationally recognized physician-scientist at Columbia University Irving Medical Center, was appointed to Pixelgen's Scientific Advisory Board in November 2025. He focuses on clonal hematopoiesis, MDS, and AML. His research into 3D DNA architecture in blood cancers is expected to help advance Pixelgen's applications in blood diseases and cancer.
  • Carolina Molecular Inc.coreChannel Partner/ Reseller/ Distributor · 12 November 2025Carolina Molecular became the first US certified service provider for Pixelgen's Proxiome Kit in November 2025. Provides academic, pharmaceutical, and biotech researchers across the US with access to Pixelgen's Proximity Network Assay for protein interactomics analysis. Leverages Carolina Molecular's NGS Foundry and bioinformatics capabilities for data delivery.
  • Mostafa Ronaghi (Cellanome / Former Illumina CTO)minorStrategic or Co-development Partner · 30 April 2024Renowned genomicist and serial entrepreneur appointed to Pixelgen's Scientific Advisory Board in April 2024. Previously served as CTO and SVP of entrepreneurial development at Illumina. Co-founded GRAIL and multiple successful life sciences companies. Brings deep expertise in genomics and entrepreneurial development to guide Pixelgen's commercial expansion.
  • Australian BiosearchsignificantChannel Partner/ Reseller/ Distributor · 6 February 2024Non-exclusive distribution agreement for Australia and New Zealand signed February 2024. Australian Biosearch brings Pixelgen's Molecular Pixelation kits to the ANZ region to meet growing customer demand. Australian Biosearch is well regarded for bringing innovative tools to industry and academia.
  • BioStream Co. Ltd (Japan)significantChannel Partner/ Reseller/ Distributor · 1 February 2024Non-exclusive distribution agreement for Japan signed February 2024. BioStream distributes Pixelgen's spatial proteomics kits to bioresearch institutions and companies in Japan. BioStream is a well-established distributor in Japan with many years of experience serving pharmaceutical and biotech companies.

Scale indicators9 records

Recent moves9 records

Expansion highlights7 records

Pixelgen Technologies competitors and assessment

Company assessment

Direct peers

  • 10x Genomics: Leading single-cell and spatial biology platform whose Xenium (in situ) and Visium products compete with Pixelgen in spatial omics for single cells. Several Pixelgen executives (Alvaro Martinez Barrio, Annika Branting, Brad Crutchfield, Tarjei Mikkelsen) are 10x alumni, and the platforms target overlapping academic and pharma customers.
  • NanoString Technologies: Spatial biology competitor with CosMx SMI (single-molecule imaging) and GeoMx digital spatial profiling, directly addressing the same translational research and immuno-oncology customer base that Pixelgen's Proxiome Kit targets.
  • Akoya Biosciences: Spatial proteomics company offering PhenoCycler (single-cell) and PhenoImager (tissue) platforms that compete in immuno-oncology and tumor microenvironment applications highly overlapping with Pixelgen's CAR-T and immune-cell surface biology focus.

Broad incumbents

  • Olink: Proteomics tools company commercializing the Proximity Extension Assay—founded by Pixelgen CEO Simon Fredriksson. Operates a much broader installed base across pharma and academic proteomics; relevant as a precedent for scaling multiplex proteomics and a likely customer-overlap competitor.
  • Standard BioTools (formerly Fluidigm): Provider of mass cytometry and imaging mass cytometry instruments for single-cell proteomics, serving similar immunology and translational research customers with established imaging-based workflows that Pixelgen's optics-free approach seeks to complement or substitute.
  • Bio-Techne: Diversified life sciences tools company with proteomics reagents (ProteinSimple, R&D Systems) and spatial biology offerings. Provides a comparable consumables-and-instruments franchise across the same academic and biopharma proteomics buyers.
  • AbCellera Biologics: Antibody discovery and immune profiling platform with single-cell B-cell sequencing capabilities relevant to immune cell characterization; competes for immuno-oncology and cell-therapy customer budget adjacent to Pixelgen's CAR-T and surface-proteomics applications.
  • Bruker: Analytical instruments manufacturer with mass spectrometry and spatial proteomics/imaging mass cytometry solutions (e.g., timsTOF, CellScape). Overlaps with Pixelgen in translational proteomics customers and in serving immunology, hematology, and pharma research labs.
  • Becton, Dickinson and Company (BD): Major life sciences and diagnostics company with flow cytometry, single-cell multiomics (BD CellView, FACSDiscover), and cell therapy manufacturing tools. Competes for immunology and cell-therapy characterization budget that Pixelgen also targets with its Proxiome CAR-T products.

Emerging players

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Pixelgen Technologies social profiles

Digital presence

Pixelgen Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pixelgen Technologies leadership team

Management profile

Number of profiles

Profiles17 records

Pixelgen Technologies funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pixelgen Technologies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pixelgen Technologies

What does Pixelgen Technologies do?

Pixelgen Technologies develops and sells the Proximity Network Assay (PNA)-powered Proxiome Kit, a sample-preparation reagent kit that uses DNA-barcoded antibodies, rolling circle amplification, and next-generation sequencing to map protein abundance, clustering, and colocalization on the surface of single immune cells at nanoscale (~50nm) resolution. The offering includes complementary modules (Custom Conjugation Kit for user-defined antibodies, CAR T barcoded spike-in antibodies), along with an open-source software suite (pixelator, pixelatorR, nf-core/pixelator, pixelatorES) for data processing and analysis on standard NGS platforms.

Is Pixelgen Technologies a public or private company?

Pixelgen Technologies is a private company. It is classified as venture growth investor backed and is currently operating.

When was Pixelgen Technologies founded?

Pixelgen Technologies was founded in 2020. It employs 11 to 50 people.

Where is Pixelgen Technologies based?

Pixelgen Technologies is headquartered in Stockholm, Sweden, in the Europe region.

How does Pixelgen Technologies make money?

Two revenue lines are on record. Spatial Proteomics Kits and Reagents are the primary driver. The others are service Provider Network Revenue.

Who are Pixelgen Technologies's main competitors?

Direct peers on record are 10x Genomics, NanoString Technologies and Akoya Biosciences. Broad incumbents are Olink, Standard BioTools (formerly Fluidigm), Bio-Techne, AbCellera Biologics, Bruker and Becton, Dickinson and Company (BD). IsoPlexis (now part of Berkley Lights' successor entities / acquired) is listed as an emerging player.

Does Pixelgen Technologies have an API?

No public API is recorded for Pixelgen Technologies.

What industry is Pixelgen Technologies in?

Pixelgen Technologies's product category is Spatial Proteomics. Its primary akta.pro industry code is HLAAALAL, Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays), with a secondary code of HLAAAMAK, Immuno-Oncology & Immune Monitoring Biomarkers (TMB, MSI, MRD, immune profiling). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
StartupmafiaBioTech Funding: Stockholm’s Pixelgen Technologies Closes $15.5M Oversubscribed Series B to Accelerate Global ExpansionStockholm-based Pixelgen Technologies closed an oversubscribed $15.5 million Series B round led by Flat Capital to accelerate global commercialization of its Proxiome Kit. The financing will support expansion into key markets and growth of its team and product portfolio. The company also added Flat Capital CEO Rickard El Tarzi and Ramon Felciano to its board.Tech.euEuropean tech weekly recap: More than 45 tech funding deals worth over €684MOver 45 European tech funding deals worth more than €684 million were tracked last week, with over 5 exits and M&A transactions. Fintech led at €239.2 million, followed by robotics and AI, while Switzerland raised the most at €172.5 million.Pulse 2.0Pixelgen Technologies Raises $15.5 Million Series B To Scale Molecular Cell Architecture Platform GloballyPixelgen Technologies has closed an oversubscribed $15.5 million Series B financing led by Flat Capital to accelerate the global commercialization of its Proxiome Kit and expand its team and product portfolio. The company, which develops a high-throughput platform for mapping molecular cell architecture at nanoscale resolution, plans to use the funds to grow its presence in key markets and further develop its data analysis software. Two new board members from Flat Capital will join Pixelgen to support this expansion into applications such as cancer and immunology research.European BiotechnologyProximity resolution: Swedish Pixelgen raises $15.5M to take cell architecture platform globalPixelgen Technologies raised $15.5 million in an oversubscribed Series B round led by Flat Capital to expand its Proxiome platform. The Swedish company's technology maps protein organization on individual cells, offering 50-nanometer resolution and 155-protein analysis. The funds will support international expansion and product growth.EU-StartupsStockholm’s Pixelgen Technologies secures €13.26 million to advance spatial mapping of cell-surface proteinsStockholm-based life sciences company Pixelgen Technologies has closed a €13.26 million Series B funding round led by Flat Capital, with participation from existing investors Industrifonden and Navigare Ventures. The company plans to use the capital to expand its global commercial reach for its Proxiome Kit platform and grow its team and product portfolio.AInvestAbundance Is the Wrong MetricPixelgen Technologies closed an oversubscribed $15.5 million Series B funding round, which was led by new investor Flat Capital alongside previous investors Industrifonden and Navigare. The funding is intended to support the Proximity Network Assay, a technology that enhances spatial cell surface analysis, emphasizing the arrangement of proteins rather than just their abundance. The company's success may depend on adoption within laboratories, given the ongoing challenges in the crowded market for spatial analysis tools.TradingViewFlat Capital leads new funding round in life science company Pixelgen TechnologiesFlat Capital is leading a SEK 150 million Series B funding round for Swedish life science company Pixelgen Technologies. The new capital will support the commercialization of Pixelgen's Proxiome Kit and its global expansion into markets in Europe and North America. This investment marks Flat Capital's entry into the life sciences sector with the goal of supporting innovative healthcare technologies.PR NewswirePixelgen Technologies Closes $15.5M Oversubscribed Series B to Accelerate Global ExpansionPixelgen Technologies closed an oversubscribed $15.5 million Series B financing round led by Flat Capital, with continued participation from existing investors Industrifonden and Navigare Ventures. The company intends to use the funds to accelerate the global commercialization of its Proxiome Kit and expand its presence in key markets. To support this growth, Pixelgen has appointed Flat Capital CEO Rickard El Tarzi and life sciences entrepreneur Ramon Felciano to its board of directors.PR NewswirePixelgen Technologies Closes $15.5M Oversubscribed Series B to Accelerate Global ExpansionPixelgen Technologies closed an oversubscribed $15.5 million Series B led by Flat Capital to accelerate global commercialization of its Proxiome Kit. The company will use the funds to expand its presence in key markets and grow its team and product portfolio.PixelgenPixelgen Technologies Closes $15.5M Oversubscribed Series B to Accelerate Global ExpansionPixelgen Technologies closed an oversubscribed $15.5 million Series B led by Flat Capital to accelerate global commercialization of its Proxiome Kit. The financing will fund expansion and product development, with Flat Capital CEO Rickard El Tarzi and Ramon Felciano joining the board.